Researchers at the University of Western Ontario have developed a Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More
Tests in cells demonstrate that these drugs increased the levels of active SMN protein; this is encouraging since low levels of this protein appears to be the cause of neuronal death that leads to SMA. More